Psoriasiform dermatitis can be either de novo or a flare-up of pre-existing psoriasis in patients treated with anti-PD-1/PD-L1, and approximately 3% of patients in Japan treated with nivolumab developed psoriasis-like reactions [42,69,70,71,72]. The gene discussed is PDCD1; the disease is Psoriasiform dermatitis.